Abstract | BACKGROUND: Carnobacterium species are lactic acid-producing Gram-positive bacteria that have been approved by the US Food and Drug Administration and Health Canada for use as a food bio-preservative. The use of live bacteria as a food additive and its potential risk of infections in immunocompromised patients are not well understood. CASE PRESENTATION: CONCLUSIONS: This is the fourth reported case of bacteremia with Carnobacterium spp. isolated from humans. This case highlights the need to better understand the pathogenicity and disease spectrum of bacteria used in the food industry for bio-preservation, especially in immunocompromised patients.
|
Authors | Carson Ka-Lok Lo, Prameet M Sheth |
Journal | BMC infectious diseases
(BMC Infect Dis)
Vol. 21
Issue 1
Pg. 403
(May 01 2021)
ISSN: 1471-2334 [Electronic] England |
PMID | 33933029
(Publication Type: Case Reports, Journal Article, Review)
|
Chemical References |
- Androgen Antagonists
- Anti-Bacterial Agents
- Vancomycin
- Amoxicillin-Potassium Clavulanate Combination
- Ceftriaxone
|
Topics |
- Aged, 80 and over
- Amoxicillin-Potassium Clavulanate Combination
(therapeutic use)
- Androgen Antagonists
(therapeutic use)
- Anti-Bacterial Agents
(therapeutic use)
- Bacteremia
(drug therapy, microbiology)
- Blood Culture
- Canada
- Carnobacterium
(isolation & purification, pathogenicity)
- Ceftriaxone
(therapeutic use)
- Food Microbiology
- Gram-Positive Bacterial Infections
(blood, drug therapy, microbiology)
- Humans
- Immunocompromised Host
- Male
- Pneumonia, Bacterial
(drug therapy, microbiology)
- Prostatic Neoplasms
(drug therapy, microbiology, pathology)
- Vancomycin
(therapeutic use)
|